PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
43.31%
Revenue growth above 1.5x RUN's 12.90%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
28.15%
Positive gross profit growth while RUN is negative. John Neff would see a clear operational edge over the competitor.
-38.47%
Negative EBIT growth while RUN is at 23.91%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
573.02%
Operating income growth above 1.5x RUN's 0.47%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
423.62%
Net income growth comparable to RUN's 460.66%. Walter Schloss might see both following similar market or cost trajectories.
423.08%
EPS growth similar to RUN's 456.14%. Walter Schloss would assume both have parallel share structures and profit trends.
423.08%
Similar diluted EPS growth to RUN's 436.85%. Walter Schloss might see standard sector or cyclical influences on both firms.
0.29%
Share reduction more than 1.5x RUN's 1.22%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
10.55%
Diluted share count expanding well above RUN's 1.26%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
57.45%
Positive OCF growth while RUN is negative. John Neff would see this as a clear operational advantage vs. the competitor.
73.33%
FCF growth under 50% of RUN's 156.78%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
No Data
No Data available this quarter, please select a different quarter.
628.87%
5Y revenue/share CAGR above 1.5x RUN's 64.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
90.49%
Positive 3Y CAGR while RUN is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
-150.34%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-68.28%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
No Data
No Data available this quarter, please select a different quarter.
457.79%
Below 50% of RUN's 1185.12%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
93.42%
Below 50% of RUN's 220.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
371.33%
5Y equity/share CAGR above 1.5x RUN's 72.95%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
37.60%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-17.97%
Firm’s AR is declining while RUN shows 8.37%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
7.14%
Inventory shrinking or stable vs. RUN's 18.52%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-15.11%
Negative asset growth while RUN invests at 4.18%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.77%
We have a declining book value while RUN shows 11.80%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-41.06%
We’re deleveraging while RUN stands at 3.38%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
19.42%
We increase R&D while RUN cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.90%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.